Skip to main content

Nonprofit · EIN 83-3947490

ROIVANT SOCIAL VENTURES INC

Tax-exempt · NEW YORK, NY 10119

Financials

$183K$246K2022$124K$255K2023$307K$287K2024
Revenue Expenses · by fiscal year end
Financials of ROIVANT SOCIAL VENTURES INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
March 31, 2025990$306,829$287,235$19,594$408,573$24,000$384,573
March 31, 2024990$123,893$254,637-$130,744$627,351$258,804$368,547
March 31, 2023990$183,093$245,560-$62,467$755,918$256,627$499,291
Financial details: 990 for the year ended March 31, 2025

Revenue

Contributions, gifts and grants
$305,032
Program service revenue
$0
Investment income
$1,797
Other revenue
$0

Expenses

Grants and similar amounts paid
$23,481
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$4,990
Accounting fees
$56,920
Travel
$8,438
Program services (functional)
$163,370
Management and general (functional)
$99,855
Fundraising (functional)
$24,010

Balance sheet and other

Total assets, start of year
$627,351
Total assets, end of year
$408,573
Total liabilities, end of year
$24,000
Net assets, end of year
$384,573
Net assets without donor restrictions
$384,573
Gross receipts
$306,829
Employees
0
Volunteers
47
Year formed
2018
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended March 31, 2025, highest compensation first.

NameTitleHours / weekCompensationFrom related orgsOther / benefits
MATTHEW GLINEDIRECTOR AND SECRETARY
Trustee or director, Officer
0.2$0$24,803,978$185,851,159
ERIC VENKERDIRECTOR
Trustee or director
0.2$0$16,220,093$5,162,135
RAKHI KUMAR TO 22025DIRECTOR AND TREASURER
Trustee or director, Officer
0.2$0$4,037,660$2,058,756
DANIEL PATTERSONDIRECTOR
Trustee or director
0.2$0$1,567,059$420,313
LINDSAY ANDROSKIDIRECTOR, PRESIDENT AND CEO
Trustee or director, Officer
4$0$1,110,342$49,318
990 for the year ended March 31, 2024: 5 people
NameTitleHours / weekCompensationFrom related orgsOther / benefits
ERIC VENKERDIRECTOR AND CHAIR
Trustee or director, Officer
0.2$0$30,854,317$21,874
RAKHI KUMARDIRECTOR AND TREASURER
Trustee or director, Officer
0.2$0$4,715,239$2,285,161
MATTHEW GLINEDIRECTOR AND SECRETARY
Trustee or director, Officer
0.2$0$5,808,808$33,138
DANIEL PATTERSONDIRECTOR
Trustee or director
0.2$0$1,933,271$8,651
LINDSAY ANDROSKIDIRECTOR, PRESIDENT AND CEO
Trustee or director, Officer
4$0$1,020,489$298,442
990 for the year ended March 31, 2023: 5 people
NameTitleHours / weekCompensationFrom related orgsOther / benefits
MATTHEW GLINEDIRECTOR AND SECRETARY
Trustee or director, Officer
0.2$0$6,440,897$47,233,582
ERIC VENEKERDIRECTOR AND CHAIR
Trustee or director, Officer
0.2$0$3,801,886$47,223,912
RAKHI KUMARDIRECTOR AND TREASURER
Trustee or director, Officer
0.2$0$1,042,188$2,880,860
LINDSAY ANDROSKIDIRECTOR, PRESIDENT AND CEO
Trustee or director, Officer
28$0$928,761$91,939
DANIEL PATTERSONDIRECTOR
Trustee or director
0.2$0$673,616$207,413

Address and contacts

Address (IRS master file)
1 PENNSYLVANIA PLAZA 54TH FL, NEW YORK, NY 10119-5501
In care of
% RACHEL RUBIN
Principal officer (990 for 2024)
LINDSAY ANDROSKI, 1 PENNSYLVANIA PLAZA 54TH FL, NEW YORK, NY 10119
Signed the 990
LINDSAY ANDROSKI, PRESIDENT AND CEO
Phone
(212) 847-6204
Return prepared by
EISNER ADVISORY GROUP LLC

Mission

SEE SCHEDULE OOUR MISSION IS TO IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS ON A NOT-FOR-PROFIT, CHARITABLE BASIS. WE USE INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. OUR WORK IS ACROSS TWO STRATEGIES: (I) INVESTMENTS AND INCUBATION LEADERSHIP TO EARLY-STAGE INNOVATIVE HEALTH ACCESS, MANUFACTURING, AND DRUG DEVELOPMENT ORGANIZATIONS WITH NO OR LOW-COST "PATIENT" CAPITAL AND RESOURCES; (II) CHARITABLE PARTNERSHIPS AND EDUCATIONAL INITIATIVES ACROSS INDUSTRY, PATIENT ADVOCACY, AND INVESTORS ACCELERATING DEVELOPMENT OF NEW MEDICINES.

990 for the year ended March 31, 2025

Program accomplishments

  • SEE SCHEDULE OTHE ORGANIZATION HAD THE FOLLOWING INITIATIVES FOR THE FISCAL-YEARENDING MARCH 31, 2025:(I) TEACHING ROIVANT SOCIAL VENTURES' "MAKING MEDICINES" COURSE AT THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL'S ESHELMAN SCHOOL OF PHARMACY, THE NUMBER ONE RANKED PHARMACY SCHOOL IN THE UNITED STATES. WE DESIGNED AND LAUNCHED THIS INNOVATIVE COURSE IN 2023 TO INTRODUCE PHARMD STUDENTS TO THE NEW DRUG APPROVAL PROCESS AND KEY ISSUES IN DRUG DISCOVERY, PRE-CLINICAL TESTING, CLINICAL TRIALS, FDA APPROVAL, AND GLOBAL ACCESS TO MEDICINES. THE COURSE IS IN HIGH DEMAND AND RECEIVED MULTIPLE TEACHING AWARDS. (II) GROWING ROIVANT SOCIAL VENTURES' INAUGURAL ACCESS TO MEDICINES PHARMA INTERNSHIPS AND ACCESS TO MEDICINES GLOBAL FELLOWSHIPS FOR TALENTED PHARMD STUDENTS FROM GROUPS WITH DISPROPORTIONATE UNMET NEEDS IN MEDICINE. IN 2023 THE PROGRAM PROVIDED REAL-WORLD DRUG DEVELOPMENT EXPERIENCE TO FOUR HIGHLY QUALIFIED PHARMD STUDENTS. IN 2024 WE EXPANDED THE PROGRAM TO FIVE STUDENTS. (III) CONTINUING OUR THOUGHT LEADERSHIP CAMPAIGN THROUGH HOSTING EVENTS LIKE "INCREASING IMPACT: LEVERAGING DATA TO DRIVE HEALTHCARE ACCESS AND ADVANCEMENT," THAT PROVIDED INCREASED VISIBILITY AND EDUCATION ON ISSUES IN HEALTHCARE ACCESS, AND SPEAKING AT EVENTS WITH ORGANIZATIONS LIKE THE TERMEER FOUNDATION, BIO'S CEO AND INVESTOR CONFERENCE, THE ADVANCING WOMEN'S LEADERSHIP IN PHARMA AND HEALTHCARE CONFERENCE, THE NATIONAL VACCINE LAW CONFERENCE, AND 50/50 WOMEN ON BOARDS. (IV) LAUNCHED OUR INAUGURAL CONVERGENCE FORUM FELLOWSHIPS, WHICH PROVIDED SUPPORT FOR HIGHLY TALENTED FIRST-TIME FEMALE AND UNDERREPRESENTED CEOS TO ATTEND AN INTIMATE, INVITATION ONLY CONFERENCE OF PROMINENT HEALTHCARE LEADERS.(V) LAUNCHING OUR HEALTH EQUITY SPOTLIGHT SERIES, WHICH HIGHLIGHTS ORGANIZATIONS INCREASING ACCESS TO RESEARCH, MEDICINE, AND MEDICAL CARE FOR UNDERSERVED PATIENT GROUPS.
    Expenses $163,370 · grants $23,481

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in March, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025March 31, 2026August 17, 2026Not on file
2024March 31, 2025August 15, 2025990 on file
2023March 31, 2024August 15, 2024990 on file

IRS record

EIN
83-3947490
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2020
Accounting year ends
March
Files
Form 990 or 990-EZ
Assets (IRS master file)
$408,573
Income (IRS master file)
$306,829

Filing history

FormYear endedRevenueExpensesAssetsReturn
990March 2025$306,829$287,235$408,573XML
990March 2024$123,893$254,637$627,351XML
990March 2023$183,093$245,560$755,918XML
990March 2022$693,792$132,277$838,064IRS
990-EZMarch 2021–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 83-3947490).

Questions about ROIVANT SOCIAL VENTURES INC

What is the EIN of ROIVANT SOCIAL VENTURES INC?
The employer identification number (EIN) of ROIVANT SOCIAL VENTURES INC is 83-3947490.
Is ROIVANT SOCIAL VENTURES INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2020.
Are donations to ROIVANT SOCIAL VENTURES INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does ROIVANT SOCIAL VENTURES INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of ROIVANT SOCIAL VENTURES INC due?
The return for tax year 2025 (the year ending March 31, 2026) is due August 17, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did ROIVANT SOCIAL VENTURES INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended March 2025.
Who is the principal officer of ROIVANT SOCIAL VENTURES INC?
The 990 for the year ended March 31, 2025 names LINDSAY ANDROSKI.
Who are the officers and directors of ROIVANT SOCIAL VENTURES INC?
The 990 for the year ended March 31, 2025 lists 5 people; 0 received compensation from the organization.
How much revenue does ROIVANT SOCIAL VENTURES INC have?
On its 990 for the year ended March 31, 2025 it reported revenue of $306,829, expenses of $287,235 and total assets of $408,573 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Philanthropy, voluntarism and grantmaking foundations